Ulrik Pedersen-Bjergaard

Ulrik Pedersen-Bjergaard

Klinisk Professor, Klinisk professor

Medlem af:


    Udgivelsesår:
    Alle
    61 - 70 ud af 165Pr. side: 10
    Sortering: 1. forfatter
    1. Udgivet

      Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

      Johansen, N. J., Dejgaard, T. F., Lund, A., Schluntz, C., Frandsen, C. S., Forman, Julie Lyng, Albrechtsen, Nicolai Jacob Wewer, Holst, Jens Juul, Pedersen-Bjergaard, Ulrik, Madsbad, Sten, Vilsbøll, Tina, Andersen, H. U. & Knop, Filip Krag, 2020, I: The Lancet Diabetes & Endocrinology. 8, 4, s. 313-324 12 s.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    2. Udgivet

      Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin-treated Type 2 diabetes mellitus

      Khunti, K., Cigrovski Berković, M., Ludvik, B., Moberg, E., Barner Lekdorf, J., Gydesen, H. & Pedersen-Bjergaard, Ulrik, 2018, I: Diabetic Medicine. 35, 9, s. 1232-1241 10 s.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    3. Udgivet

      Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

      Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsen, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., Kapur, R., Lalic, N., Ludvik, B., Moberg, E., Pedersen-Bjergaard, Ulrik, Ramachandran, A. & HAT Investigator Group, H. I. G., sep. 2016, I: Diabetes, Obesity and Metabolism. 18, 9, s. 907-915 9 s.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    4. Udgivet

      Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes

      Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., Kapur, R., Lalic, N., Ludvik, B., Moberg, E., Pedersen-Bjergaard, Ulrik, Ramachandran, A. & HAT Investigator Group, H. I. G., 2017, I: Diabetes Research and Clinical Practice. 130, s. 121-129

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    5. Udgivet

      Oral treatment of glucocorticoid-induced diabetes mellitus: A systematic review

      Klarskov, C. K., Holm Schultz, H., Wilbek Fabricius, T., Persson, F., Pedersen-Bjergaard, Ulrik & Kristensen, Peter Lommer, 2020, I: International Journal of Clinical Practice. 74, 8, e13529.

      Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

    6. Udgivet

      Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment

      Klarskov, C. K., Holm Schultz, H., Persson, F., Møller Christensen, T., Almdal, T. P., Snorgaard, O., Bagge Hansen, K., Pedersen-Bjergaard, Ulrik & Lommer Kristensen, P., 15 jun. 2020, I: BMC Endocrine Disorders. 20, 1, 11 s., 86.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    7. Udgivet

      Biomarkers for Development of Glucocorticoid-Induced Diabetes Mellitus: A Metabolomics-Based Prediction Model

      Klarskov, C. K., Havelund, J., Zegers, F. D., Faergeman, N. J., Lawaetz Schultz, H. H., Debrabant, B., Pedersen-Bjergaard, Ulrik & Christensen, P. L., 2020, I: Journal of Molecular and Genetic Medicine. 14, 4, 7 s.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    8. Udgivet

      Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial

      Klarskov, C. K., Windum, N. A., Olsen, M. T., Dungu, A. M., Jensen, Andreas Kryger, Lindegaard, Birgitte, Pedersen-Bjergaard, Ulrik & Kristensen, Peter Lommer, 2022, I: Diabetes Technology & Therapeutics. 24, 2, 11 s.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    9. Udgivet

      Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial

      Klarskov, C. K., Lindegaard, Birgitte, Pedersen-Bjergaard, Ulrik & Kristensen, Peter Lommer, 2020, I: Trials. 21, 1, 968.

      Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

    10. Udgivet

      Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes

      Kristensen, Peter Lommer, Pedersen-Bjergaard, Ulrik, Schalkwijk, C., Olsen, N. V. & Thorsteinsson, B., sep. 2010, I: European Journal of Endocrinology. Supplement. 163, 3, s. 391-8 8 s.

      Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

    Forrige 1...3 4 5 6 7 8 9 10 ...17 Næste

    ID: 5472759